Global Over-The-Counter (OTC) Drugs Market Insights and Forecast to 2026

SKU ID :QYR-15948795 | Published Date: 20-Jul-2020 | No. of pages: 111
1 Study Coverage 1.1 Over-The-Counter (OTC) Drugs Product Introduction 1.2 Market Segments 1.3 Key Over-The-Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type 1.4.2 Cold and Flu Products 1.4.3 Analgesics 1.4.4 Dermatological Products 1.4.5 Gastrointestinal Products 1.4.6 Vitamin 1.4.7 Other 1.5 Market by Application 1.5.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Over-The-Counter (OTC) Drugs Market Size, Estimates and Forecasts 2.1.1 Global Over-The-Counter (OTC) Drugs Revenue 2015-2026 2.1.2 Global Over-The-Counter (OTC) Drugs Sales 2015-2026 2.2 Global Over-The-Counter (OTC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Over-The-Counter (OTC) Drugs Competitor Landscape by Players 3.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers 3.1.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020) 3.1.2 Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Over-The-Counter (OTC) Drugs Revenue by Manufacturers 3.2.1 Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Over-The-Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Over-The-Counter (OTC) Drugs Revenue in 2019 3.2.5 Global Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Over-The-Counter (OTC) Drugs Price by Manufacturers 3.4 Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Product Types 3.4.1 Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Over-The-Counter (OTC) Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Over-The-Counter (OTC) Drugs Market Size by Type (2015-2020) 4.1.1 Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) 4.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020) 4.1.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Over-The-Counter (OTC) Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Over-The-Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Over-The-Counter (OTC) Drugs Market Size by Application (2015-2020) 5.1.1 Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) 5.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Application (2015-2020) 5.1.3 Over-The-Counter (OTC) Drugs Price by Application (2015-2020) 5.2 Over-The-Counter (OTC) Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Over-The-Counter (OTC) Drugs Price Forecast by Application (2021-2026) 6 North America 6.1 North America Over-The-Counter (OTC) Drugs by Country 6.1.1 North America Over-The-Counter (OTC) Drugs Sales by Country 6.1.2 North America Over-The-Counter (OTC) Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Type 6.3 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Over-The-Counter (OTC) Drugs by Country 7.1.1 Europe Over-The-Counter (OTC) Drugs Sales by Country 7.1.2 Europe Over-The-Counter (OTC) Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Type 7.3 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Over-The-Counter (OTC) Drugs by Region 8.1.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region 8.1.2 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Type 8.3 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Over-The-Counter (OTC) Drugs by Country 9.1.1 Latin America Over-The-Counter (OTC) Drugs Sales by Country 9.1.2 Latin America Over-The-Counter (OTC) Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Over-The-Counter (OTC) Drugs Market Facts & Figures by Type 9.3 Central & South America Over-The-Counter (OTC) Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Over-The-Counter (OTC) Drugs by Country 10.1.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country 10.1.2 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 Bayer 11.1.1 Bayer Corporation Information 11.1.2 Bayer Description and Business Overview 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered 11.1.5 Bayer Related Developments 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Corporation Information 11.2.2 Boehringer Ingelheim Description and Business Overview 11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Products Offered 11.2.5 Boehringer Ingelheim Related Developments 11.3 GSK 11.3.1 GSK Corporation Information 11.3.2 GSK Description and Business Overview 11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020) 11.3.4 GSK Over-The-Counter (OTC) Drugs Products Offered 11.3.5 GSK Related Developments 11.4 Novartis 11.4.1 Novartis Corporation Information 11.4.2 Novartis Description and Business Overview 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Novartis Over-The-Counter (OTC) Drugs Products Offered 11.4.5 Novartis Related Developments 11.5 Pfizer 11.5.1 Pfizer Corporation Information 11.5.2 Pfizer Description and Business Overview 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Pfizer Over-The-Counter (OTC) Drugs Products Offered 11.5.5 Pfizer Related Developments 11.6 PGT healthcare 11.6.1 PGT healthcare Corporation Information 11.6.2 PGT healthcare Description and Business Overview 11.6.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020) 11.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Products Offered 11.6.5 PGT healthcare Related Developments 11.7 Sanofi 11.7.1 Sanofi Corporation Information 11.7.2 Sanofi Description and Business Overview 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Sanofi Over-The-Counter (OTC) Drugs Products Offered 11.7.5 Sanofi Related Developments 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Corporation Information 11.8.2 Teva Pharmaceuticals Description and Business Overview 11.8.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered 11.8.5 Teva Pharmaceuticals Related Developments 11.9 Takeda 11.9.1 Takeda Corporation Information 11.9.2 Takeda Description and Business Overview 11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Takeda Over-The-Counter (OTC) Drugs Products Offered 11.9.5 Takeda Related Developments 11.10 Cipla 11.10.1 Cipla Corporation Information 11.10.2 Cipla Description and Business Overview 11.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Cipla Over-The-Counter (OTC) Drugs Products Offered 11.10.5 Cipla Related Developments 11.1 Bayer 11.1.1 Bayer Corporation Information 11.1.2 Bayer Description and Business Overview 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered 11.1.5 Bayer Related Developments 11.12 Glenmark 11.12.1 Glenmark Corporation Information 11.12.2 Glenmark Description and Business Overview 11.12.3 Glenmark Sales, Revenue and Gross Margin (2015-2020) 11.12.4 Glenmark Products Offered 11.12.5 Glenmark Related Developments 11.13 Innovus Pharmaceuticals 11.13.1 Innovus Pharmaceuticals Corporation Information 11.13.2 Innovus Pharmaceuticals Description and Business Overview 11.13.3 Innovus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.13.4 Innovus Pharmaceuticals Products Offered 11.13.5 Innovus Pharmaceuticals Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Region 12.1.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions 2021-2026 12.1.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Regions 2021-2026 12.2 North America Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026) 12.2.1 North America: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026) 12.2.2 North America: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026) 12.2.3 North America: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026) 12.3 Europe Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026) 12.3.1 Europe: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026) 12.3.2 Europe: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026) 12.3.3 Europe: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Over-The-Counter (OTC) Drugs Market Size Forecast by Region (2021-2026) 12.5 Latin America Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026) 12.5.1 Latin America: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026) 12.5.2 Latin America: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026) 12.5.3 Latin America: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Over-The-Counter (OTC) Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Over-The-Counter (OTC) Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables Table 1. Over-The-Counter (OTC) Drugs Market Segments Table 2. Ranking of Global Top Over-The-Counter (OTC) Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Cold and Flu Products Table 5. Major Manufacturers of Analgesics Table 6. Major Manufacturers of Dermatological Products Table 7. Major Manufacturers of Gastrointestinal Products Table 8. Major Manufacturers of Vitamin Table 9. Major Manufacturers of Other Table 10. Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 11. Global Over-The-Counter (OTC) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 12. Global Over-The-Counter (OTC) Drugs Sales by Regions 2015-2020 (K Units) Table 13. Global Over-The-Counter (OTC) Drugs Sales Market Share by Regions (2015-2020) Table 14. Global Over-The-Counter (OTC) Drugs Revenue by Regions 2015-2020 (US$ Million) Table 15. Global Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020) (K Units) Table 16. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturers (2015-2020) Table 17. Global Over-The-Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Over-The-Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2019) Table 19. Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Over-The-Counter (OTC) Drugs Price (2015-2020) (USD/Unit) Table 22. Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Over-The-Counter (OTC) Drugs Product Type Table 24. Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units) Table 27. Global Over-The-Counter (OTC) Drugs Sales Share by Type (2015-2020) Table 28. Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020) (US$ Million) Table 29. Global Over-The-Counter (OTC) Drugs Revenue Share by Type (2015-2020) Table 30. Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 31. Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units) Table 32. Global Over-The-Counter (OTC) Drugs Sales Share by Application (2015-2020) Table 33. North America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units) Table 34. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020) Table 35. North America Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 36. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020) Table 37. North America Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units) Table 38. North America Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020) Table 39. North America Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units) Table 40. North America Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020) Table 41. Europe Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units) Table 42. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020) Table 43. Europe Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 44. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020) Table 45. Europe Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units) Table 46. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020) Table 47. Europe Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units) Table 48. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020) Table 49. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region (2015-2020) (K Units) Table 50. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region (2015-2020) Table 51. Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2015-2020) (US$ Million) Table 52. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2015-2020) Table 53. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units) Table 54. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020) Table 55. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units) Table 56. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020) Table 57. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units) Table 58. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020) Table 59. Latin Americaa Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 60. Latin America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020) Table 61. Latin America Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units) Table 62. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020) Table 63. Latin America Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units) Table 64. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020) Table 65. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units) Table 66. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020) Table 67. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 68. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020) Table 69. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units) Table 70. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020) Table 71. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units) Table 72. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020) Table 73. Bayer Corporation Information Table 74. Bayer Description and Major Businesses Table 75. Bayer Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Bayer Product Table 77. Bayer Recent Development Table 78. Boehringer Ingelheim Corporation Information Table 79. Boehringer Ingelheim Description and Major Businesses Table 80. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Boehringer Ingelheim Product Table 82. Boehringer Ingelheim Recent Development Table 83. GSK Corporation Information Table 84. GSK Description and Major Businesses Table 85. GSK Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. GSK Product Table 87. GSK Recent Development Table 88. Novartis Corporation Information Table 89. Novartis Description and Major Businesses Table 90. Novartis Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Novartis Product Table 92. Novartis Recent Development Table 93. Pfizer Corporation Information Table 94. Pfizer Description and Major Businesses Table 95. Pfizer Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Pfizer Product Table 97. Pfizer Recent Development Table 98. PGT healthcare Corporation Information Table 99. PGT healthcare Description and Major Businesses Table 100. PGT healthcare Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. PGT healthcare Product Table 102. PGT healthcare Recent Development Table 103. Sanofi Corporation Information Table 104. Sanofi Description and Major Businesses Table 105. Sanofi Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Sanofi Product Table 107. Sanofi Recent Development Table 108. Teva Pharmaceuticals Corporation Information Table 109. Teva Pharmaceuticals Description and Major Businesses Table 110. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Teva Pharmaceuticals Product Table 112. Teva Pharmaceuticals Recent Development Table 113. Takeda Corporation Information Table 114. Takeda Description and Major Businesses Table 115. Takeda Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Takeda Product Table 117. Takeda Recent Development Table 118. Cipla Corporation Information Table 119. Cipla Description and Major Businesses Table 120. Cipla Over-The-Counter (OTC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Cipla Product Table 122. Cipla Recent Development Table 123. Sun Pharmaceutical Industries Corporation Information Table 124. Sun Pharmaceutical Industries Description and Major Businesses Table 125. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. Sun Pharmaceutical Industries Product Table 127. Sun Pharmaceutical Industries Recent Development Table 128. Glenmark Corporation Information Table 129. Glenmark Description and Major Businesses Table 130. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. Glenmark Product Table 132. Glenmark Recent Development Table 133. Innovus Pharmaceuticals Corporation Information Table 134. Innovus Pharmaceuticals Description and Major Businesses Table 135. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. Innovus Pharmaceuticals Product Table 137. Innovus Pharmaceuticals Recent Development Table 138. Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions (2021-2026) (K Units) Table 139. Global Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Regions (2021-2026) Table 140. Global Over-The-Counter (OTC) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million) Table 141. Global Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Regions (2021-2026) Table 142. North America: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units) Table 143. North America: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 144. Europe: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units) Table 145. Europe: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 146. Asia Pacific: Over-The-Counter (OTC) Drugs Sales Forecast by Region (2021-2026) (K Units) Table 147. Asia Pacific: Over-The-Counter (OTC) Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 148. Latin America: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units) Table 149. Latin America: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 150. Middle East and Africa: Over-The-Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K Units) Table 151. Middle East and Africa: Over-The-Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 152. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 153. Key Challenges Table 154. Market Risks Table 155. Main Points Interviewed from Key Over-The-Counter (OTC) Drugs Players Table 156. Over-The-Counter (OTC) Drugs Customers List Table 157. Over-The-Counter (OTC) Drugs Distributors List Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Over-The-Counter (OTC) Drugs Product Picture Figure 2. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Cold and Flu Products Product Picture Figure 4. Analgesics Product Picture Figure 5. Dermatological Products Product Picture Figure 6. Gastrointestinal Products Product Picture Figure 7. Vitamin Product Picture Figure 8. Other Product Picture Figure 9. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2020 & 2026 Figure 10. Hospital Pharmacy Figure 11. Retail Pharmacy Figure 12. Online Pharmacy Figure 13. Over-The-Counter (OTC) Drugs Report Years Considered Figure 14. Global Over-The-Counter (OTC) Drugs Market Size 2015-2026 (US$ Million) Figure 15. Global Over-The-Counter (OTC) Drugs Sales 2015-2026 (K Units) Figure 16. Global Over-The-Counter (OTC) Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region (2015-2020) Figure 18. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2019 Figure 19. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2015-2020) Figure 20. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2019 Figure 21. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturer in 2019 Figure 22. The Top 10 and 5 Players Market Share by Over-The-Counter (OTC) Drugs Revenue in 2019 Figure 23. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020) Figure 25. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2019 Figure 26. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2015-2020) Figure 27. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type in 2019 Figure 28. Global Over-The-Counter (OTC) Drugs Market Share by Price Range (2015-2020) Figure 29. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020) Figure 30. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2019 Figure 31. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2015-2020) Figure 32. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application in 2019 Figure 33. North America Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 34. North America Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 35. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019 Figure 36. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019 Figure 37. U.S. Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 38. U.S. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Canada Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. Canada Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. North America Over-The-Counter (OTC) Drugs Market Share by Type in 2019 Figure 42. North America Over-The-Counter (OTC) Drugs Market Share by Application in 2019 Figure 43. Europe Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 44. Europe Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 45. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019 Figure 46. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019 Figure 47. Germany Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. Germany Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. France Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. France Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. U.K. Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. U.K. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Italy Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Italy Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Russia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Russia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Europe Over-The-Counter (OTC) Drugs Market Share by Type in 2019 Figure 58. Europe Over-The-Counter (OTC) Drugs Market Share by Application in 2019 Figure 59. Asia Pacific Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2019 Figure 62. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2019 Figure 63. China Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. China Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. India Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Asia Pacific Over-The-Counter (OTC) Drugs Market Share by Type in 2019 Figure 86. Asia Pacific Over-The-Counter (OTC) Drugs Market Share by Application in 2019 Figure 87. Latin America Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 88. Latin America Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 89. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019 Figure 90. Latin America Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019 Figure 91. Mexico Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 92. Mexico Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Brazil Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 94. Brazil Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Argentina Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 96. Argentina Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Latin America Over-The-Counter (OTC) Drugs Market Share by Type in 2019 Figure 98. Latin America Over-The-Counter (OTC) Drugs Market Share by Application in 2019 Figure 99. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 100. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 101. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019 Figure 102. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019 Figure 103. Turkey Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 104. Turkey Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Saudi Arabia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 106. Saudi Arabia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. U.A.E Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 108. U.A.E Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. Middle East and Africa Over-The-Counter (OTC) Drugs Market Share by Type in 2019 Figure 110. Middle East and Africa Over-The-Counter (OTC) Drugs Market Share by Application in 2019 Figure 111. North America Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 112. North America Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Europe Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 114. Europe Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Asia Pacific Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 116. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Latin America Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 118. Latin America Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 120. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Porter's Five Forces Analysis Figure 122. Channels of Distribution Figure 123. Distributors Profiles Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients